Literature DB >> 415004

Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.

O R Pavlovskis, B H Iglewski, M Pollack.   

Abstract

The data presented indicate that one of the primary actions of Pseudomonas aeruginosa exotoxin during experimental infection is the inactivation of elongation factor 2 (EF-2) in various mouse organs. Organs from mice infected with the toxigenic P. aeruginosa strain PA103 contained considerably less EF-2 activity than did organs from uninfected controls. Whereas EF-2 activity was reduced in all organs examined from PA103-infected animals, the largest decrease was observed in the liver, where the active EF-2 levels were reduced by 70 to 90%. In addition, consistent inhibition of protein synthesis in livers but not in other organs was observed in mice infected with the toxigenic PA103 strain. Treatment of mice with antitoxin before infection with strain PA103 prevented inactivation of EF-2. When mice were infected with lethal doses of the nontoxigenic P. aeruginosa WR5 strain, tissue EF-2 levels were not markedly reduced below those derived from uninfected control animals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415004      PMCID: PMC414043          DOI: 10.1128/iai.19.1.29-33.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  The elongation factor 2 content of mammalian cells. Assay method and relation to ribosome number.

Authors:  D M Gill; L L Dinius
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

2.  Studies on transferase II using diphtheria toxin.

Authors:  D M Gill; A M Pappenheimer; J B Baseman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1969

3.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

5.  Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.

Authors:  C B Saelinger; K Snell; I A Holder
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

6.  Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.

Authors:  M Pollack; N S Taylor
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

7.  Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo.

Authors:  B H Iglewski; P V Liu; D Kabat
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  Incidence of exotoxin production by Pseudomonas species.

Authors:  M J Bjorn; M L Vasil; J C Sadoff; B H Iglewski
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity.

Authors:  J L Middlebrook; R B Dorland
Journal:  Can J Microbiol       Date:  1977-02       Impact factor: 2.419

10.  Temperature-dependent inactivating factor of Pseudomonas aeruginosa exotoxin A.

Authors:  M L Vasil; P V Liu; B H Iglewski
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.609

View more
  27 in total

1.  Biological effects of Pseudomonas aeruginosa exotoxin A: lymphoproliferation of T lymphocytes in athymic mice.

Authors:  P S Holt; M L Misfeldt
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

2.  Comparison of the exoS gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa.

Authors:  M W Ferguson; J A Maxwell; T S Vincent; J da Silva; J C Olson
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Variables which affect suppression of the immune response induced by Pseudomonas aeruginosa exotoxin A.

Authors:  P S Holt; M L Misfeldt
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

4.  Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.

Authors:  M M Lieberman; D C McKissock; G L Wright
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

5.  Effects of pseudomonas toxin A, diphtheria toxin, and cholera toxin on electrical characteristics of turtle bladder.

Authors:  W A Brodsky; J C Sadoff; J H Durham; G Ehrenspeck; M Schachner; B H Iglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia.

Authors:  G B Stover; D R Drake; T C Montie
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

7.  Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.

Authors:  S J Cryz; F Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

9.  Regions of toxin A involved in toxin A excretion in Pseudomonas aeruginosa.

Authors:  A N Hamood; J C Olson; T S Vincent; B H Iglewski
Journal:  J Bacteriol       Date:  1989-04       Impact factor: 3.490

10.  Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages.

Authors:  M Pollack; S E Anderson
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.